IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 216 filers reported holding IMMUNOGEN INC in Q2 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,598,398 | -12.3% | 541,802 | +4.3% | 0.00% | 0.0% |
| Q2 2023 | $9,802,551 | +36.6% | 519,478 | -72.2% | 0.00% | 0.0% |
| Q1 2023 | $7,177,048 | -12.6% | 1,869,023 | +12.9% | 0.00% | 0.0% |
| Q4 2022 | $8,208,173 | +44.8% | 1,654,874 | +39.5% | 0.00% | 0.0% |
| Q3 2022 | $5,670,000 | -16.3% | 1,186,337 | -21.2% | 0.00% | 0.0% |
| Q2 2022 | $6,773,000 | -2.6% | 1,505,249 | +3.1% | 0.00% | 0.0% |
| Q1 2022 | $6,951,000 | -13.6% | 1,460,432 | +34.7% | 0.00% | 0.0% |
| Q4 2021 | $8,042,000 | +75.5% | 1,083,865 | +34.1% | 0.00% | – |
| Q3 2021 | $4,582,000 | -13.5% | 807,997 | +0.5% | 0.00% | -100.0% |
| Q2 2021 | $5,296,000 | -16.1% | 803,584 | +3.1% | 0.00% | 0.0% |
| Q1 2021 | $6,312,000 | +20.4% | 779,151 | -4.2% | 0.00% | 0.0% |
| Q4 2020 | $5,243,000 | +65.4% | 813,005 | -7.6% | 0.00% | – |
| Q3 2020 | $3,169,000 | -26.0% | 880,278 | -5.5% | 0.00% | -100.0% |
| Q2 2020 | $4,285,000 | +23.1% | 931,385 | -8.7% | 0.00% | 0.0% |
| Q1 2020 | $3,480,000 | -37.7% | 1,020,486 | -6.8% | 0.00% | 0.0% |
| Q4 2019 | $5,588,000 | +92.5% | 1,094,485 | -8.7% | 0.00% | – |
| Q3 2019 | $2,903,000 | +14.7% | 1,199,240 | +2.9% | 0.00% | – |
| Q2 2019 | $2,530,000 | -53.2% | 1,165,845 | -41.6% | 0.00% | -100.0% |
| Q1 2019 | $5,410,000 | +41.8% | 1,996,090 | +151.1% | 0.00% | 0.0% |
| Q4 2018 | $3,816,000 | -51.3% | 794,907 | -4.0% | 0.00% | 0.0% |
| Q3 2018 | $7,840,000 | -33.6% | 827,915 | -31.8% | 0.00% | -50.0% |
| Q2 2018 | $11,804,000 | +12.6% | 1,213,221 | +21.7% | 0.00% | 0.0% |
| Q1 2018 | $10,486,000 | +59.8% | 996,801 | -2.7% | 0.00% | +100.0% |
| Q4 2017 | $6,564,000 | -50.7% | 1,024,044 | -41.1% | 0.00% | -50.0% |
| Q3 2017 | $13,302,000 | +61.8% | 1,738,761 | +50.4% | 0.00% | 0.0% |
| Q2 2017 | $8,219,000 | +58.6% | 1,156,001 | -13.7% | 0.00% | +100.0% |
| Q1 2017 | $5,183,000 | +109.7% | 1,339,518 | +10.5% | 0.00% | 0.0% |
| Q4 2016 | $2,472,000 | -33.6% | 1,211,823 | -12.8% | 0.00% | 0.0% |
| Q3 2016 | $3,724,000 | -6.6% | 1,389,343 | +7.3% | 0.00% | 0.0% |
| Q2 2016 | $3,988,000 | -57.9% | 1,294,614 | +16.4% | 0.00% | -50.0% |
| Q1 2016 | $9,472,000 | -29.2% | 1,111,773 | +12.8% | 0.00% | -33.3% |
| Q4 2015 | $13,372,000 | +44.3% | 985,379 | +2.1% | 0.00% | +50.0% |
| Q3 2015 | $9,265,000 | +784.9% | 965,094 | +1226.1% | 0.00% | – |
| Q2 2015 | $1,047,000 | +426.1% | 72,776 | +228.9% | 0.00% | – |
| Q1 2015 | $199,000 | -18.8% | 22,129 | -44.7% | 0.00% | – |
| Q4 2014 | $245,000 | -86.9% | 40,023 | -77.3% | 0.00% | -100.0% |
| Q3 2014 | $1,864,000 | +323.6% | 176,019 | +374.9% | 0.00% | – |
| Q2 2014 | $440,000 | +249.2% | 37,062 | +336.7% | 0.00% | – |
| Q1 2014 | $126,000 | -4.5% | 8,486 | -5.5% | 0.00% | – |
| Q4 2013 | $132,000 | -41.1% | 8,978 | -31.7% | 0.00% | – |
| Q3 2013 | $224,000 | -57.0% | 13,147 | -58.2% | 0.00% | – |
| Q2 2013 | $521,000 | – | 31,438 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |